Skip to main navigation Skip to search Skip to main content

MIR137 schizophrenia-associated locus controls synaptic function by regulating synaptogenesis, synapse maturation and synaptic transmission

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

The MIR137 locus is a replicated genetic risk factor for schizophrenia. The risk-associated allele is reported to increase miR- 137 expression and miR-137 overexpression alters synaptic transmission in mouse hippocampus. We investigated the cellular mechanisms underlying these observed effects in mouse hippocampal neurons in culture. First, we correlated the risk allele to expression of the genes in the MIR137 locus in human postmortem brain. Some evidence for increased MIR137HG expression was observed, especially in hippocampus of the disease-associated genotype. Second, in mouse hippocampal neurons, we confirmed previously observed changes in synaptic transmission upon miR-137 overexpression. Evoked synaptic transmission and spontaneous release were 50% reduced. We identified defects in release probability as the underlying cause. In contrast to previous observations, no evidence was obtained for selective synaptic vesicle docking defects. Instead, ultrastructural morphometry revealed multiple effects of miR-137 overexpression on docking, active zone length and total vesicle number. Moreover, proteomic analyses of neuronal protein showed that expression of Syt1 and Cplx1, previously reported as downregulated upon miR-137 overexpression, was unaltered. Immunocytochemistry of synapses overexpressing miR-137 showed normal Synaptotagmin1 and Complexin1 protein levels. Instead, our proteomic analyses revealed altered expression of genes involved in synaptogenesis. Concomitantly, synaptogenesis assays revealed 31% reduction in synapse formation. Taken together, these data show that miR-137 regulates synaptic function by regulating synaptogenesis, synaptic ultrastructure and synapse function. These effects are plausible contributors to the increased schizophrenia risk associated with miR-137 overexpression.

Original languageEnglish
Pages (from-to)1879-1891
Number of pages13
JournalHuman Molecular Genetics
Volume27
Issue number11
DOIs
Publication statusPublished - 1 Jun 2018

Funding

The authors thank Sara Grasman for immunocytochemical experiments and morphometry and Rien Dekker for the electron microscopy. We also thank Dr Ronald E. van Kesteren and Dr Pim van Nierop for discussion of the project. We thank Rob Zwart and Marieke van Ziel for their help on qPCR experiment. This work was supported by the Swedish Research Council (VR Dnr: 538-2013-8865 to P.F.S.), the European Union (ERC Advanced grant 322966 to M.V.; HEALTH-F2-2009-241498 EUROSPIN to M.V. and HEALTH-F2-2009-242167 SynSys to A.B.S. and M.V.), The Netherlands Organization for Scientific Research (NWO VICI 453-14-005 to D.P.). The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH and NINDS. The data used for the analyses described in this article were obtained fromthe GTEx Portal on February 17, 2016. Funding to pay the Open Access publication charges for this article was provided by Section of Functional Genomics, Faculty of Science, Vrije Universiteit Amsterdam. This work was supported by the Swedish Research Council (VR Dnr: 538–2013-8865 to P.F.S.), the European Union (ERC Advanced grant 322966 to M.V.; HEALTH-F2–2009-241498 EUROSPIN to M.V. and HEALTH-F2–2009-242167 SynSys to A.B.S. and M.V.), The Netherlands Organization for Scientific Research (NWO VICI 453– 14-005 to D.P.). The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH and NINDS. The data used for the analyses described in this article were obtained from the GTEx Portal on February 17, 2016. Funding to pay the Open Access publication charges for this article was provided by Section of Functional Genomics, Faculty of Science, Vrije Universiteit Amsterdam.

FundersFunder number
Netherlands Organization for Scientific Research
National Institutes of Health
National Institute of Mental HealthU01MH109528
National Institute on Drug Abuse
National Heart, Lung, and Blood Institute
National Human Genome Research Institute
National Cancer Institute
National Institute of Neurological Disorders and Stroke
European Commission
European Research Council322966, HEALTH-F2–2009-242167
Nederlandse Organisatie voor Wetenschappelijk OnderzoekVICI 453– 14-005
Vetenskapsrådet538–2013-8865
National Institute of Development Administration

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'MIR137 schizophrenia-associated locus controls synaptic function by regulating synaptogenesis, synapse maturation and synaptic transmission'. Together they form a unique fingerprint.

    Cite this